Smart Inhalers Market 2017 Global Trend, Segmentation and Opportunities Forecast To 2023
Marketresearchfuture.Com published a Cooked
research report on “Global Smart
Inhalers Market Research Report - Forecast to 2023”– Market Analysis,
Scope, Progress, Trends and Forecast to 2022.
The Global Smart Inhalers Market is
growing continuously and expected to grow at a CAGR of 42.8% during the
forecast period 2017-2023. Smart Inhaler is a part of new age digital
technology which is designed to improve the disease management in the
respiratory diseases. Smart Inhalers are basically the respiratory inhalers
equipped with a digital sensor. The sensor installed in the inhaler tracks the
data such as the dosage timing, monitors the use of the inhaler, and schedules
the next dosage. Smart Inhalers can generate alerts for the daily dosage for
the user using the smart devices connected to the sensors via Bluetooth.
Smart inhaler technology is quickly becoming one of
the most valuable areas of pharmaceutical engagement in digital health. There
has been rise in number of companies that are adopting this digital technology
and opting to use it to enhance the management of lung disorders such as asthma
and chronic obstructive pulmonary disorder (COPD), as well as improve the
efficacy of the prescribed medications. Wide variety of benefits ranging from
improving medication adherence to reducing hospital admissions, which makes
smart inhalers the next big thing of respiratory care segment.
According to a recent study report published by the
Market Research Future, The Global Smart Inhalers Market is
booming and expected to gain prominence over the forecast period growing
rapidly. The market is forecasted to demonstrate a spectacular growth by 2023,
surpassing its previous growth records in terms of value with a prominent CAGR
during the anticipated period (2017 – 2023).
Smart Inhalers Market has
been driven by various factors including their advantage over conventional
inhalers technological advancements, improving adherence to inhalers, linking
with telehealth, and also due to extensive use of smart computing devices. Due
to these reasons the market is expected to rise further in the coming future.
Simultaneously other factors restricting the market growth includes data
security concern related to security devices, regulating government policies
for the use of healthcare devices, and also limited availability of these
products in potential emerging market and regions.
Smart Inhalers Market Key
Players:
Adherium Limited (New Zealand), AstraZeneca
(England), Cohero Health (USA), GlaxoSmithKline (U.K.), Gecko Health
Innovations Inc (USA), Inspiro Medical Ltd., and Propeller Health (USA) are
some of the prominent players at the forefront of competition in the Global
Smart Inhalers Market and are profiled in MRFR Analysis.
Global Smart
Inhalers Market - Competitive Analysis
The market for smart inhalers is characterised by
the presence of several well-established and small players, the Global
Smart Inhalers Market appears to be highly competitive and fragmented.
Major players are increasingly expanding their footprint in the emerging
nations, making it putting pressure on the regional players, especially in
terms of features such as type, product portfolios, and pricing. The market is
witnessing intensified competition which is expected to get more intensified
further during the forecast period. There has been rise in number of companies
that are adopting this digital technology and opting to use it to enhance the
management of lung disorders such as asthma and chronic obstructive pulmonary
disorder (COPD), as well as improve the efficacy of the prescribed
medications.
For instance, Adherium’s partnering and market
expansion for the ‘Rest of World’ territories, including countries in Asia
Pacific and the Middle East where Adherium already has sanctions to market its Smart
inhaler products in China, Australia and New Zealand. This will increase the
company’s strength in these countries.
Moreover, AstraZeneca, multinational pharmaceutical
and biopharmaceutical Company had recently started its expansion in respiratory
business with the acquisition of respiratory business of Tadeka Pharmaceuticals
in 2016, and also with partnership with Adherium, for the supplies of smart
inhaler and sensors.
In January 2017, AstraZeneca announced that on 25
January 2017 the US Food and Drug Administration (FDA) granted six months of
paediatric exclusivity for Symbicort (budesonide/formoterol) Inhalation
Aerosol. Symbicort is approved in the US to treat asthma in patients 12 years
and older and for the maintenance and treatment of COPD in adults, the company
is expecting larger market share with the product launch.
Gecko Health Innovations, Inc., acquired by Teva
Pharmaceutical in 2015, focusing on cloud-based solution to simplify chronic
respiratory disease management, and connect patients and caregivers through
remote monitoring and real-time tools. The major driving factors for the
company’s growth in the market are due to increasing technological advancements
and need for integrated cloud based technologies in the treatment of
respiratory diseases.
Therefore, the growing acquisitions and clinical
approvals for various competitive products by the major players has spurred the
growth of the market.
Brief Table
Of Content
Chapter1
Market Introduction
Chapter 2 Research Methodology
Chapter 3
Market Dynamics
Chapter 4 Market Factor Analysis
Chapter 5
Global Smart Inhalers Market, By Type
Chapter 6 Global Smart Inhalers
Market, By Application
Chapter 7 Global Smart Inhalers
Market, By End User
Chapter 8
Global Smart Inhalers Market, By Region
Chapter 9 Competitive Landscape
Chapter 10 Company Profiles
Chapter 11 List Of Tables
Chapter 12 List Of Figures
…Continued
Think To Buy
It : https://www.marketresearchfuture.com/checkout?currency=one_user-USD&report_id=2117 .
What We Provide In
Reports:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Market Research Future recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends.
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Market Research Future recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends.
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
About Market Research
Future:
At Market Research Future
(MRFR), we enable our customers to unravel the complexity of various industries
through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR),
Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research
& Consulting Services.
Contact:
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com
Comments
Post a Comment